↓ Skip to main content

Cochrane Database of Systematic Reviews

Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer

Overview of attention for article published in Cochrane database of systematic reviews, December 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
6 news outlets
blogs
1 blog
policy
1 policy source
twitter
13 X users
reddit
1 Redditor

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
96 Mendeley
Title
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer
Published in
Cochrane database of systematic reviews, December 2020
DOI 10.1002/14651858.cd013257.pub2
Pubmed ID
Authors

Roberto Ferrara, Martina Imbimbo, Reem Malouf, Sophie Paget-Bailly, François Calais, Corynne Marchal, Virginie Westeel

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 96 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 10%
Student > Bachelor 8 8%
Researcher 7 7%
Other 6 6%
Student > Doctoral Student 5 5%
Other 14 15%
Unknown 46 48%
Readers by discipline Count As %
Medicine and Dentistry 19 20%
Biochemistry, Genetics and Molecular Biology 6 6%
Nursing and Health Professions 6 6%
Social Sciences 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 9 9%
Unknown 48 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 64. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2023.
All research outputs
#664,093
of 25,312,451 outputs
Outputs from Cochrane database of systematic reviews
#1,238
of 13,047 outputs
Outputs of similar age
#18,269
of 522,012 outputs
Outputs of similar age from Cochrane database of systematic reviews
#19
of 181 outputs
Altmetric has tracked 25,312,451 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,047 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 522,012 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 181 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.